Late Effects of Conformal Radiation Therapy for Pediatric Patients With Low-Grade Glioma: Prospective Evaluation of Cognitive, Endocrine, and Hearing Deficits
Top Cited Papers
- 1 August 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (22) , 3691-3697
- https://doi.org/10.1200/jco.2008.21.2738
Abstract
Purpose: We conducted a prospective trial to evaluate late effects in pediatric patients with low-grade glioma (LGG) treated with conformal radiation therapy (CRT). Patients and Methods: Between August 1997 and August 2006, 78 pediatric patients with LGG (mean age, 9.7 years; standard deviation, ±4.4 years) received 54 Gy of CRT with a 10-mm clinical target volume margin. Tumor locations were diencephalon (n = 58), cerebral hemisphere (n = 3), and cerebellum (n = 17). Baseline and serial evaluations were performed to identify deficits in cognition, endocrine function, and hearing. Deficits were correlated with clinical factors and radiation dose within specific normal tissue volumes. Results: Cognitive effects of CRT through 5 years after CRT correlated with patient age, neurofibromatosis type 1 status, tumor location and volume, extent of resection, and radiation dose. The effect of age exceeded that of radiation dose; patients younger than 5 years experienced the greatest decline in cognition. Before CRT, growth hormone (GH) secretion abnormality was diagnosed in 24% of tested patients, and 12% had precocious puberty. The 10-year cumulative incidence of GH replacement was 48.9%; of thyroid hormone replacement, 64.0%; of glucocorticoid replacement, 19.2%; and of gonadotropin-releasing hormone analog therapy, 34.2%. The mean ± standard errors of the cumulative incidence of hearing loss at 10 years did not exceed 5.7% ± 3.3% at any frequency. Conclusion: To our knowledge, this is the largest series of prospectively followed children with LGG to undergo irradiation. Adverse effects are limited and predictable for most patients; however, this study provides additional evidence that CRT should be delayed for young patients and identifies the potential benefits of reducing radiation dose to normal brain.Keywords
This publication has 29 references indexed in Scilit:
- Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade GliomaJournal of Clinical Oncology, 2009
- Hearing Loss After Radiotherapy for Pediatric Brain Tumors: Effect of Cochlear DoseInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomasBritish Journal of Ophthalmology, 2007
- Clinical and Molecular Characteristics of Malignant Transformation of Low-Grade Glioma in ChildrenJournal of Clinical Oncology, 2007
- Infarctus cérébral secondaire à une artériopathie radique intracrânienne, vingt-quatre ans après une irradiation encéphaliqueRevue Neurologique, 2007
- Cognitive Profile of Neurofibromatosis Type 1Seminars in Pediatric Neurology, 2006
- Low Grade Chiasmatic-Hypothalamic Glioma - Carboplatin and Vincristin Chemotherapy Effectively Defers Radiotherapy within a Comprehensive Treatment StrategyKlinische Padiatrie, 2004
- Radiation therapy of optico–hypothalamic gliomas (OHG) – radiographic response, vision and late toxicityRadiotherapy and Oncology, 2000
- Growth and endocrine disorders in optic gliomaEuropean Journal of Pediatrics, 1990
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988